Active Pharmaceutical Ingredients (API)

From the long-term perspective, the production and sales of active pharmaceutical substances belonging to the group of generics, i.e. active substances for which the original patent protection expired, has a key role for the performance of the Company. They account for up to 95 per cent of the Company's total turnover.

At the moment, we have over 150 customers from over 50 countries from all over the world.

FARMAK, a.s. is very strongly export-oriented. Exports account for up to 90 per cent of the company's total sales. The most important trading territories are Europe, the United States of America, and selected Asian states. In recent years, the Company has been successful in penetrating markets in new territories, such as Latin America, Russia, or Japan.

FARMAK, a.s. has also built a very stable position on the domestic market.

The sales activities of the Company are supported by active participation in a number of international trade fairs, such as, for example CPhI Worldwide a DCAT v New Yorku.

more information

Contract production

Production specializes mainly in the chemistry of heterocyclic compounds, utilizing many basic chemical reactions (including Grignard reactions) in several production plants in compliance with the Good Manufacturing Practice.

The production is realized in stainless steel and enamel reactors with a capacity up to 6300 litres, in an auxiliary production facility, on centrifuges, in drying rooms and on drying filters. The finalization of production consists of sieving, grinding and micronization eventually and final packaging of the products. Production facilities are subject to SÚKL inspections and some of them even to FDA auditing.